PINZI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.958
AS - Asia 3.035
EU - Europa 2.413
SA - Sud America 513
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 75
OC - Oceania 6
Totale 12.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.743
IT - Italia 1.083
SG - Singapore 911
CN - Cina 743
HK - Hong Kong 428
BR - Brasile 393
VN - Vietnam 358
GB - Regno Unito 347
SE - Svezia 256
BD - Bangladesh 132
DE - Germania 122
RU - Federazione Russa 108
FI - Finlandia 99
ID - Indonesia 99
CA - Canada 97
KR - Corea 85
IN - India 74
NL - Olanda 62
FR - Francia 59
AR - Argentina 44
MX - Messico 41
UA - Ucraina 41
LT - Lituania 40
TR - Turchia 38
BG - Bulgaria 35
ES - Italia 34
IQ - Iraq 26
JP - Giappone 24
BE - Belgio 21
PL - Polonia 21
CO - Colombia 19
EC - Ecuador 19
IE - Irlanda 19
VE - Venezuela 18
ZA - Sudafrica 18
AT - Austria 17
PK - Pakistan 14
AE - Emirati Arabi Uniti 13
UZ - Uzbekistan 13
IR - Iran 12
CR - Costa Rica 11
PH - Filippine 11
GT - Guatemala 10
TT - Trinidad e Tobago 10
EG - Egitto 9
HN - Honduras 9
KE - Kenya 9
CH - Svizzera 8
SA - Arabia Saudita 8
TN - Tunisia 8
JM - Giamaica 7
MA - Marocco 7
PR - Porto Rico 6
UY - Uruguay 6
CL - Cile 5
GP - Guadalupe 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
RO - Romania 5
SC - Seychelles 5
SV - El Salvador 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HR - Croazia 4
KZ - Kazakistan 4
LK - Sri Lanka 4
MY - Malesia 4
NI - Nicaragua 4
NP - Nepal 4
SN - Senegal 4
AO - Angola 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
PE - Perù 3
PY - Paraguay 3
SI - Slovenia 3
AL - Albania 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
KH - Cambogia 2
MD - Moldavia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BJ - Benin 1
CI - Costa d'Avorio 1
Totale 11.986
Salva come PNG Salva come JPEG
Città #
Ashburn 704
Santa Clara 659
Singapore 475
Hong Kong 414
Fairfield 406
San Jose 349
Council Bluffs 331
Chandler 288
Hefei 214
Nyköping 182
Woodbridge 171
Modena 157
Beijing 152
Seattle 145
Houston 135
London 135
Ho Chi Minh City 126
Milan 121
Cambridge 120
Los Angeles 118
Wilmington 112
Southend 109
Bologna 89
Hanoi 89
Ann Arbor 88
Chicago 87
The Dalles 84
New York 83
Helsinki 82
Seoul 81
Jakarta 74
Princeton 44
San Diego 44
Dallas 42
Dearborn 38
Reggio Emilia 37
Jacksonville 36
Rome 36
Shanghai 36
Boardman 35
São Paulo 34
Buffalo 32
Sofia 32
Parma 31
Lauterbourg 29
Salt Lake City 29
Naples 25
Orem 24
Munich 23
Toronto 22
Denver 20
Moscow 20
Tampa 20
Tokyo 20
Washington 20
Brussels 19
Phoenix 19
Elk Grove Village 18
Atlanta 17
Warsaw 17
Frankfurt am Main 16
Nuremberg 16
Brooklyn 15
Chennai 15
Eugene 15
Haiphong 15
Mexico City 15
Kent 14
Rio de Janeiro 14
Mumbai 13
Poplar 13
Redondo Beach 13
Amsterdam 12
Izmir 12
Montreal 12
Stockholm 12
Bari 11
Biên Hòa 11
Da Nang 11
Formigine 11
Lappeenranta 11
North Bergen 11
Vienna 11
Boston 10
Dublin 10
Guangzhou 10
Johannesburg 10
Kilburn 10
Tashkent 10
Baghdad 9
Bogotá 9
Des Moines 9
Florence 9
Frattamaggiore 9
Las Vegas 9
Miano 9
Nairobi 9
San Francisco 9
San José 9
Turin 9
Totale 7.657
Salva come PNG Salva come JPEG
Nome #
An unexpected reversal in the pharmacological stereoselectivity of benzothiadiazine AMPA positive allosteric modulators 408
Molecular docking: Shifting paradigms in drug discovery 396
Antifungal Activity and DNA Topoisomerase Inhibition of Hydrolysable Tannins from Punica granatum L. 352
On the integration of in silico drug design methods for drug repurposing 338
Identification of small-molecule EGFR allosteric inhibitors by high-Throughput docking 327
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 326
Selection of protein conformations for structure-based polypharmacology studies 324
Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank 312
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease 304
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space 301
Identification of 4-aryl-1H-pyrrole[2,3-b]pyridine derivatives for the development of new B-Raf inhibitors 290
Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR 285
Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models 281
Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 280
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 267
Design of dual inhibitors of histone deacetylase 6 and heat shock protein 90 265
Computational polypharmacology comes of age 251
LigAdvisor: A versatile and user-friendly web-platform for drug design 251
Dual Targeting Strategies On Histone Deacetylase 6 (HDAC6) And Heat Shock Protein 90 (Hsp90) 243
Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity 242
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 242
2-Phenyloxazole-4-carboxamide as a Scaffold for Selective Inhibition of Human Monoamine Oxidase B 241
Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies 218
Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers 210
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 208
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies 204
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing 202
Refinement and rescoring of virtual screening results 199
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase 197
How drug repurposing can advance drug discovery: challenges and opportunities 193
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications 193
Virtual screening for dual Hsp90/B-Raf inhibitors 191
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring 191
Repositioning natural products in drug discovery 190
In silico repositioning of cannabigerol as a novel inhibitor of the enoyl acyl carrier protein (ACP) reductase (INHA) 188
Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors 184
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 182
Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction 175
Development and application of LigAdvisor, a user-friendly web-platform for polypharmacology and drug repurposing 173
Development of machine learning classifiers to predict compound activity on prostate cancer cell lines 165
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B 161
On the development of B-Raf inhibitors acting through innovative mechanisms 156
Exploring Biological Targets of Magnolol and Honokiol and their Nature-Inspired Synthetic Derivatives: In Silico Identification and Experimental Validation of Estrogen Receptors 148
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR 147
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 135
LigAdvisor: a web platform designed for charting novel polypharmacology and drug repurposing routes from crystallographic ligands and known drugs 131
LigAdvisor: a web server to perform in silico explorations on crystallographic ligands and known drugs for polypharmacology and drug repurposing. 130
Targeting the allosteric sites of the B-Raf protein kinase through an in silico approach 127
Rational design of dual inhibitors of Hsp90 and B-Raf as a novel pharmacological approach against melanomas 126
Trends and Applications in Computationally Driven Drug Repurposing 119
Unveiling target associations for polypharmacology from analysis of crystallographic ligands in the Protein Data Bank 114
Polypharmacology predictions in the Protein Data Bank 112
Tackling polypharmacology and drug repurposing with the LigAdvisor webserver. 110
Rational design of dual inhibitors of Hsp90 and Braf as a novel pharmacological approach against melanomas 101
Predicting drug polypharmacology using structural databases 100
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 54
Design, synthesis and biological activity of glycoconjugated ADAMTS5 exosite inhibitors: applications in osteoarthritis and ovarian cancer models 45
Improving Machine Learning Classification Predictions through SHAP and Features Analysis Interpretation 37
Design, synthesis, and biological evaluation of chalcone derivatives as selective Monoamine Oxidase-B inhibitors with potential neuroprotective effects 36
Selective imaging probes for differential detection of pathological tau polymorphs in tauopathies 28
Totale 12.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.820
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.820
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022599 0 0 0 0 19 36 49 61 88 54 192 100
2022/2023900 105 129 70 84 87 107 37 96 107 25 36 17
2023/2024772 28 44 52 73 138 55 98 111 17 14 48 94
2024/20252.503 63 19 66 185 482 309 133 182 215 279 255 315
2025/20264.141 284 183 345 548 590 212 492 189 425 382 335 156
2026/20271.402 145 259 275 652 71 0 0 0 0 0 0 0
Totale 12.106